tiprankstipranks
Trending News
More News >
pc:enh58

Enhanced Genomics

Enhanced Genomics is a biotechnology company specializing in 3D multi-omics to identify genetically validated drug targets for complex genetic diseases. Utilizing a proprietary platform and cell type-specific atlas, the company translates disease-associated data into actionable insights, enhancing the probability of success in pharmaceutical development. Enhanced Genomics focuses on addressing unmet medical needs in common diseases, including autoimmune conditions, by developing effective therapies through strategic partnerships with pharma and biotech sectors.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$19M
Total Amount Raised$19M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$19M
Latest Funding Amount$19M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 16, 2025
Series A
$19.00M

Investors

Investor Name
Funding Round
Series A
Series A
Series A

Related News and Analysis